Skip to main content
Toggle navigation
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Red Recording
Sig Meeting
Browse by Poster Title
Home
Browse by Poster Title
Browse by Poster Title
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Sort by
#
Sort by
Title
A
CR 12
A Case Report of HaNDL
Favorite
CR 6
A Cluster Out Of The Blue: Drug-Induced Cluster Headache
Favorite
O 4
A Dynamic Threshold Framework for Migraine: From Hypothalamic Hub to Network Instability
Favorite
CP 11
A Knowledge Graph Based Differential Diagnosis Engine for Headache Disorders
Favorite
PS 2
A Mouse Carrying an SCN1A Variant Associated with Hemiplegic Migraine Demonstrates Increased Thermal Pain Sensitivity
Favorite
CR 17
A Painful Case of Seeing Double: Utility of a High-Dose Steroid Trial in a 25-year-old Male with Painful Ophthalmoplegia
Favorite
T 32
A phase 3, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of zavegepant for the acute treatment of migraine in Asian adults
Favorite
CR 25
A rare case of new onset headaches simultaneous imaging findings of both idiopathic intracranial hypertension and low intracranial pressure on MRI
Favorite
E 36
A Retrospective Review of Patient Demographics and Socioeconomic Factors Associated with Clinic “No-Shows” at a Tertiary Headache Center.
Favorite
T 45
A Review of the History and Pharmacology of Anti- Nausea Medications
Favorite
E 8
A Single Institution Study of Stroke Code Activations for Headache and Migraine Presentations
Favorite
E 57
A U.S. multicenter patient survey in the primary care setting reveals high burden and management opportunities for severe headache and migraine
Favorite
E 6
Actigraphic sleep patterns in US Hispanic/Latino adults with migraine: The Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
Favorite
T 68
Acute Treatment of Migraine with Rimegepant Improves Health-Related Quality of Life and Reduces Headache-Related Disability: Results from a Single-Arm, Prospective, Real-World Study
Favorite
TR 12
Advanced Diffusion Imaging and Magnetic Resonance Elastography Reveals Microstructural and Biomechanical Changes in Idiopathic Intracranial Hypertension
Favorite
TR 3
Age-Related Differences in Cerebrospinal Fluid Opening Pressure Among Pediatric Patients Evaluated for Intracranial Hypertension: An Exploratory Analysis from the Childhood Headache & Intracranial Pressure Study (UT-CHIPS)
Favorite
HE 8
AI-Generated Simulated Patients as a Tool to Enhance Primary Headache Disorder Treatment Education: A Pilot Study
Favorite
T 65
Amlodipine for Migraine Prevention
Favorite
CR 20
An Unusual Cause of Severe Headache and Convexity Subarachnoid Hemorrhage
Favorite
E 30
Associations Between Migraine and Dementia: A Cross-Sectional Cohort Study of Veterans Health Administration Patients
Favorite
CR 4
Atogepant for Refractory Migraine in MELAS Syndrome: A Case Report
Favorite
B
PS 5
Behavioral and pharmacological characterization of the isosorbide dinitrate model of headache in male and female rats
Favorite
HE 25
Beyond Self-Reported Osmophobia: Chemical Odor Sensitivity Assessment and Clinical Profiles in Migraine
Favorite
E 31
Birth Planning and Outcomes in a United States Cohort of Women with Migraine: Results from a Cross-Institutional Observational Analysis
Favorite
T 13
Blood Pressure Changes With Atogepant in Overweight and Obese Persons With Migraine and Baseline Hypertension: Interim Analysis of a Phase 3, Multicenter, Open-label, 156-Week Extension Study
Favorite
HE 13
Bridging Patient Centered and Evidence-Based Headache Education to Healthcare Professionals in Africa-A survey analysis
Favorite
HE 17
Building Access: Early Experience from a Multidisciplinary Headache Clinic in Southwest Virginia
Favorite
C
PS 9
Calcitonin gene-related peptide induces brain-wide alterations in local field potential and blood oxygen level-dependent activity
Favorite
CR 24
Cardiac Toothache Mimicking Temporomandibular Joint Disorder: A Common Symptom with Life-Threatening Implications
Favorite
CR 3
Case Report: Glossopharyngeal Neuralgia vs Short-lasting Unilateral Neuralgiform headache attacks with Autonomic symptoms
Favorite
TR 4
Cerebrospinal Fluid Opening Pressure and Optical Coherence Tomography Retinal Nerve Fiber Layer in Pediatric Intracranial Hypertension: Exploratory Analysis from the Childhood Headache & Intracranial Pressure Study (UT-CHIPS)
Favorite
CR 23
Cervical dystonia presenting to the headache specialist: A case report and review of literature
Favorite
E 25
Characteristics of daily near-continuous headache in children and adolescents
Favorite
T 14
Characterizing Menstrual Migraine: Multi-Country Results from the Chronic Migraine Epidemiology and Outcomes-International (CaMEO-I) Study
Favorite
TR 9
Characterizing inflammation in pediatric patients with migraine and high exposure to adverse childhood experiences
Favorite
CR 11
Chronic Intranasal Steroid Use and Cluster Headache Suppression: A Case Report
Favorite
HE 26
Chronic Migraine Shared Medical Appointments: A Quality Improvement Initiative Addressing Stigma, Disability, Depression, and Anxiety
Favorite
E 50
Clinical Profile of Reversible Cerebral Vasoconstriction Syndrome in Japan: An Inpatient Cohort from a Regional Headache Center
Favorite
E 56
Cognitive Debriefing and Content Validation of Patient-Reported Outcomes Measurement Information System Cognitive Function Abilities–Subset Short Form 6a Version 2.0 (PROMIS-CF)
Favorite
E 37
Community Health Worker Integration into Migraine Care: A Model For Scalable Migraine Screening
Favorite
E 53
Comparative Cardiovascular Outcomes of GLP-1RAs versus SGLT2is in Patients with Obesity and Migraine: A 3-Year Real-World Study
Favorite
TR 8
Comparative Diagnostic Performance of a Supervised Machine-Learning Model and a Large Language Model in Classifying Headache Disorders Using Structured Questionnaires
Favorite
T 49
Comparative Efficacy and Safety of CGRP Monoclonal Antibodies Versus Oral Gepants for Episodic Migraine Prevention: A Bayesian Network Meta-analysis of Randomized Controlled Trials
Favorite
T 24
Comparative Efficacy of Symbravo® vs. Gepants for Acute Treatment of Migraine: A Network Meta-Analysis
Favorite
CP 17
Comparative Evaluation of Domain-Specific and General-Purpose Large Language Models for ICHD-3 Headache Diagnosis: A Controlled Simulation Study
Favorite
CP 21
Comparative Performance of LP-Derived Craniospinal Elastance Algorithms and Their Relationship to Venous Manometry in Refractory IIH
Favorite
CP 10
Comparing diagnostic rates of migraine by sex using expanded capture of nausea-related symptoms
Favorite
T 39
Comparison of FDA approved intranasal acute migraine treatment adverse event profiles
Favorite
HE 29
Comprehensive Headache Management Program (CHAMP): Initial analysis of outcomes from a Veterans’ Administration (VA) interdisciplinary program for veterans with chronic headaches
Favorite
PS 6
Conditioned media from CGRP-stimulated primary cultures of vascular smooth muscle cells induce migraine-like responses following application to the mouse dura
Favorite
HE 11
Confidence in Migraine Management Declines as Clinical Complexity Increases Among Emergency Medicine Residents
Favorite
T 25
Consistency of Ubrogepant for the Acute Treatment of Migraine Across Consecutive Migraine Attacks: Results from a 52-Week Long-Term Extension Trial
Favorite
T 26
Consistent efficacy of eptinezumab across countries in adults with CM and MOH who also received patient education: Results from the RESOLUTION trial
Favorite
D
T 71
Deficits in the Peripheral Sympathetic Nervous System Are Common in Patients with Migraine and Associate with Calcitonin-Gene Related Peptide (CGRP) Monoclonal Antibody (mAb) Treatment Response
Favorite
T 51
Delayed remission in primary trigeminal neuralgia after microvascular decompression surgeries
Favorite
T 85
Developing Research Partnerships to Support Recruitment and Engagement While Conducting a National Migraine Randomized Clinical Trial
Favorite
TR 13
Diagnostic Accuracy of Serum CGRP Levels in Migraine: A Systematic Review and Meta-analysis
Favorite
E 55
Digital Assessment of Objective and Patient-Reported Cognition Across Migraine Phases: Results from the MIND Cohort
Favorite
T 81
Digital Milestones and Public Interest in CGRP-Targeting Migraine Therapies: An Infodemiology Study in the United States
Favorite
T 56
Digital Therapeutics and App-Based Behavioral Interventions for Migraine: A Systematic Review and Meta-Analysis of Clinical Outcomes
Favorite
TR 2
Discordance Between Symptom Burden and Disease Severity in Pediatric Intracranial Hypertension: An Exploratory Analysis from the Childhood Headache & Intracranial Pressure Study (UT-CHIPS)
Favorite
T 54
Disease Course and Treatment Response of Visual Snow Syndrome : A Prospective Study in a Korean Population
Favorite
PS 1
Dissecting the potential role of a cerebellar-cingulate circuit in mouse migraine-like behaviors.
Favorite
CR 9
Dose by Dose: Making Eptinezumab Possible Through Desensitization
Favorite
T 17
Dose escalation to eptinezumab 300 mg: A subgroup analysis of the 60-week, open-label SUNSET trial in Japanese participants with chronic migraine who experienced suboptimal response
Favorite
E
HE 22
Early Exposure, Lasting Impact: Educational Outcomes of the Chicago Headache Center & Research Institute 8-Week Intensive Summer Research Internship Program in Headache and Migraine Medicine
Favorite
T 11
Effect of Adding Atogepant to OnabotulinumtoxinA on Symptoms-Free Days: Results from a Phase 3, Multicenter, 24-Week Open-Label Study (UNCHAINED)
Favorite
T 28
Effectiveness of Remote Electrical Neuromodulation (REN) Wearable for Migraine Prevention in Reducing Attack Duration and Frequency: A Real-World Study
Favorite
T 55
Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS) Units for Headache Treatment in a United States Population.
Favorite
TR 1
Effects of Astrocytic Metabolic Dysfunction and Glucose Stress on Gene Expression During Cortical Spreading Depression
Favorite
TR 7
Effects of Psilocybin on Serum CGRP and PACAP in Migraine: Preliminary Results from Two Clinical Trial Participants
Favorite
T 80
Effects of Spectral Modulation of White Light on Migraine Pain and Photophobia During Acute Attacks
Favorite
T 93
Efficacy and safety of calcitonin gene-related peptide (CGRP) monoclonal antibodies—erenumab, galcanezumab, and eptinezumab in episodic and chronic migraine.
Favorite
T 46
Efficacy and safety of rimegepant in the acute treatment of migraine among Chinese adults: real-world evidence from a multicenter, prospective, observational study
Favorite
T 89
Efficacy and Tolerability of IV Dihydroergotamine in Treating Pediatric Headache in the Emergency Department: A Retrospective Review
Favorite
T 1
Efficacy of celecoxib oral solution in the acute treatment of patients with morning migraine: a post-hoc subgroup analysis of Study 006 and 007
Favorite
T 48
Efficacy of CGRP-Targeted Gepants and Topiramate for Migraine Prevention: A Frequentist Meta-analysis
Favorite
T 52
Efficacy of Combined Curcumin and Omega-3 Supplementation in the Management of Migraine: A Systematic Review of Randomized Controlled Trials
Favorite
T 84
Efficacy of eptinezumab in patients refractory to CGRP targeted preventive treatments or onabotulinum toxin A for migraine: a retrospective cohort study
Favorite
T 90
Efficacy of Neuromodulation Devices for Migraine Prevention: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Favorite
T 47
Efficacy of rimegepant for acute migraine attacks presenting with dizziness or vertigo: a post-hoc analysis of a multicenter, prospective, real-world study
Favorite
T 50
Efficacy of Rimegepant in Patients with Vertigo: A Real-World Retrospective Study of Vestibular and Cochlear Outcomes
Favorite
T 41
Efficacy of Ubrogepant 100 mg Based on Prior Triptan Experience: Results From the ACHIEVE I Study
Favorite
T 69
Efficacy of Very Low Carbohydrate Diet on Glucose Dysregulation in Chronic Migraine
Favorite
T 16
Establishing Structural and Functional Comparability Between ABP 450 and OnabotulinumtoxinA to Support Biosimilarity
Favorite
E 3
Evaluating “No-Show” Appointments in a Tertiary Pediatric Headache Center: Understanding Preventable Causes and Demographic Relationships.
Favorite
E 15
Expanded Analysis of Aura Diversity and Progression in 90 Patients with Hemiplegic Migraine at a Tertiary Headache Center in Japan
Favorite
HE 28
Exploring a treat-to-goal approach for migraine prevention: patient perspectives on migraine preventive treatment goals
Favorite
HE 20
Exploring Primary Care Providers’ Engagement with Headache Care to Enhance Implementation of Guideline-Concordant Headache Care within the Veterans Health Administration
Favorite
CR 2
Eye See the Problem: When a ‘Migraine' Was Actually Trochleitis
Favorite
F
T 82
Facilitators and Barriers to Eptinezumab Administration in Thailand: Preliminary Qualitative Findings from the FACEpi Study
Favorite
E 51
Factors Associated with Receiving a “Headache” or “Tension-Type Headache” vs “Migraine” Diagnosis Among Arizona Medicaid Recipients: Demographics and Social Determinants of Health
Favorite
E 38
Factors influencing interictal executive function in migraine: follow-up study
Favorite
E 10
Fatigue Is Highly Prevalent in Individuals With Migraine: A Nationwide Population-Based Study
Favorite
T 38
Feasibility of Middle Meningeal Artery Embolization with n-Butyl Cyanoacrylate for Refractory Chronic Migraine: MIGRAINE Study Preliminary Results
Favorite
CR 1
Freezing ON with POCUS: Management of Occipital Neuralgia with Point of Care Ultrasound and Cryoneurolysis
Favorite
T 8
Fremanezumab for the Preventive Treatment of Episodic and Chronic Migraine in Children and Adolescents: Safety Outcomes From the SPACE Program
Favorite
G
E 45
Gastrointestinal Comorbidities Associated with Chronic Migraine: a Retrospective, Observational Analysis
Favorite
HE 9
Generation of Board-Quality Headache Medicine Questions Using Knowledge Graph–Augmented LLMs
Favorite
T 70
Genetic Factors Associated With Ketamine Response Kinetics in Refractory Migraine
Favorite
E 43
Geographic Variation in Headache Specialist Distribution and Access to Care in the United States
Favorite
H
CP 20
Headache Attributed to a Past Spontaneous Intracranial Hypotension: a new diagnostic entity
Favorite
T 29
Headache hours with severe pain intensity during long-term treatment with eptinezumab: Post hoc analysis of the DELIVER trial
Favorite
E 44
Headache in Moyamoya Disease: Prevalence, Longitudinal Course, and Treatment Outcomes
Favorite
CP 13
Headache in Service Members and Veterans (SMVs) with Severe TBI: A Two-Year Analysis of Prevalence, Intensity, and Frequency
Favorite
E 46
Headache Not Otherwise Specified in Veterans: Evidence of Undiagnosed Migraine
Favorite
CP 14
Headaches in the Elderly: Clinical Characteristics
Favorite
E 58
Healthcare resource utilization and costs among individuals newly diagnosed with migraine: An analysis of claims data from third-party payers in the United States
Favorite
CR 10
Hemicrania Continua-Like Headache Secondary to Cavernous Sinus Inflammatory Pseudotumor
Favorite
CR 26
Hemiplegic Migraine Type 2: A Case Based Phenotypic Analysis and Responsiveness to Ubrogepant
Favorite
I
CP 15
Iatrogenic Cerebrospinal Fluid Leak Following Presacral Cyst Excision
Favorite
T 79
Identifying and Targeting Potential Misrepresentation in Virtual Clinical Migraine Trials
Favorite
HE 2
Impact of a Clinical Decision Support Pathway for Migraine in the Urgent Care Setting
Favorite
E 54
Impact of American College of Radiology Appropriateness Criteria Adherence on Emergency Department Length of Stay in Patients Presenting with Headache
Favorite
HE 5
Improving Access to Intravenous Migraine Rescue Therapy Through an Urgent Care Rapid Referral Pathway: A Quality Improvement Project
Favorite
HE 14
Improving Access to Migraine Care for Women of Color: Early Reach and Evaluation Framework of a Narrative-Based Educational Intervention
Favorite
HE 21
Improving the Quality and Consistency of Pediatric Headache Evaluations Through Implementation of a Standardized Headache Template in Neurology Clinics.
Favorite
T 6
In vitro Profile of Elismetrep: A Potent and Highly Selective Blocker of the Migraine-Associated Channel TRPM8
Favorite
E 52
Increased Risk of Incident Dementia Subtypes Associated with Vitamin D Insufficiency in Patients with Migraine: A Global Real-World Analysis
Favorite
HE 12
Increasing Headache care Access by Integration of Clinical Pharmacy Providers ( CPP) at ALM VA Headache Center of Excellence (HCoE)
Favorite
HE 15
Integrated Psychology Services in Multidisciplinary Pediatric Headache Clinics: A Descriptive Program Evaluation
Favorite
HE 6
Integrating Headache Screening into Obstetric Care: A Quality Improvement Initiative
Favorite
E 16
Interictal Burden and Disability Predict Attack-Related Worsening in Mood and Cognitive Symptoms: The MIND Cohort
Favorite
E 56
Introducing the MIND Study: A Smartphone-Based Cohort for High-Frequency Assessment of Cognition and Symptoms in Migraine
Favorite
PS 4
Investigating the role of Treg cells and Interleukin-2 in reversing mTBI-induced neurobehavioral changes: implications of IL-10 and TGFβ pathways
Favorite
E 49
Is Migraine a Risk Factor for Alzheimer’s Disease?: A Meta-analysis of Observational and Mendelian Randomization Studies
Favorite
HE 10
It turns me into a different person: A qualitative study of irritability among US veterans with cluster headache, migraine and post-traumatic headache
Favorite
L
CR 8
Laughing Before the Storm: A Case of Gelastic Migraine
Favorite
E 34
Lifestyle and Behavioural Adaptations Among Middle-Aged and Older Adults with Migraine: A Population-Based Cross-Sectional Study Examining Findings from the Canadian Longitudinal Study on Aging (CLSA)
Favorite
T 2
Long-Term Safety, Tolerability, and Efficacy of Atogepant for the Preventive Treatment of Migraine: Final Results from a Phase 3, Open-Label, 156-Week, Long-Term Safety Extension Study
Favorite
E 4
Long-Term Trends in Headache Disorders in the United States: Prevalence and Disability Burden from 1990 to 2023
Favorite
M
CR 21
Methylergonavine: Alternative to Repetitive Dihydroergotamine for Refractory Migraine
Favorite
E 63
Migraine and Oral Health: Intersections with Temporomandibular Disorders, Periodontal Disease, and Clinical Knowledge Gaps
Favorite
F 3
Migraine aura status and patent foramen ovale – Case report
Favorite
E 60
Migraine Burden of Illness Among a Commercially Insured US Population (IFORM-I)
Favorite
E 61
Migraine in America Symptoms and Treatment (MAST) Study: A Subgroup Analysis of Women with Perimenstrual Headache (MAST-MM)
Favorite
CP 6
Migraine in America Symptoms and Treatment (MAST) Study: Evaluating Burden and Disability in a Subgroup of Women with Perimenstrual Headache (MAST-MM)
Favorite
E 35
Migraine in Low-Income Communities: Prevalence, Care Practices, and Access Barriers - A Cross-Sectional Study
Favorite
HE 16
Migraine Perception and Lived Experiences on College Campuses: Qualitative Analysis of Semi-Structured Virtual Focus Groups Among College Students
Favorite
E 21
Migraine Trajectories Across the Menopausal Transition by Aura Status in the Nurses’ Health Study 2
Favorite
CR 13
Migraine with Olfactory Aura (phantosmia) responsive to Galcanezumab: a case report
Favorite
E 11
Migraine, Tension-Type Headache and Non-Specific Headache in Children and Adolescents with Autism-Spectrum Disorder
Favorite
E 39
Migraine-Associated Risk of Cervical Artery Dissection: A Systematic Review and Meta-Analysis
Favorite
PS 3
Migraine-like phenotypes are influenced by age and sex in a mouse model of chronic migraine
Favorite
E 19
Migraine-related Stigma as a Stressor: Associations between Migraine-Related Stigma and Experimental Pain Sensitivity
Favorite
CP 5
Migrainous Cardialgia: When the Headache Hurts the Heart — A Multicenter, Retrospective Case Series
Favorite
CP 18
Misophonia Among Those with Migraine: Associations with Psychological Burden and Other Sensory Sensitivities
Favorite
CP 4
Multisensory Symptoms and Headache Impact as associated factors of Photophobia in Migraine
Favorite
E 23
Multisite pain burden measured by body map screening predicts reduced triptan responsiveness in adults with migraine, highlighting centralized pain mechanisms beyond formal COPC diagnoses.
Favorite
N
CP 7
Natural Language Processing of Clinical Notes to Support Primary Care Diagnosis of Migraine
Favorite
CP 9
Neuroanatomic and Phenotypic Associations of Secondary Headache After Acute Cerebrovascular Injury
Favorite
CP 16
New Daily Persistent Headache Phenotypically Consistent with Low Pressure Headache in a Man with Multiple Suspicious Spinal Pathologies
Favorite
CP 19
New onset of migraine with aura as presentation of subclinical epileptic activity and neurodegenerative disease
Favorite
O
T 58
Occipital Nerve Block Efficacy in Neurocritical ICU (NICU) Patients with Acute Cephalgia
Favorite
T 88
Olanzapine as a Bridge Therapy for Status Migranosus: A Retrospective Study of Dosing and Duration
Favorite
T 63
Olanzapine in the Treatment of Status Migrainosus
Favorite
T 66
Once-Nightly Pregabalin for Co-occurring Headaches, Nonrestorative Sleep, and Nightmares
Favorite
P
E 47
Pain Sensitivity Questionnaire is a valid measure of central sensitization in individuals with migraine
Favorite
CP 3
Pathogenesis of varicella-zoster virus-associated brainstem encephalitis: insights from brainstem lesions associated with patients with facial herpes zoster.
Favorite
CP 23
Patient Burden of Migraine Disease: Results from a Mixed Methods U.S. Study
Favorite
CP 22
Patient Demographics and Provider Role Are Associated With Non-Contrast Head CT Ordering Patterns in Emergency Department Headache Presentations
Favorite
T 78
Patient Global Impression of Change Following Inpatient Treatment for Intractable Migraine
Favorite
T 4
Patient Treatment Satisfaction With OnabotulinumtoxinA Versus Topiramate for Chronic Migraine
Favorite
F 4
Patient-Reported Benefits of Group-Based Online Mindfulness for Migraine: A Qualitative Study
Favorite
T 91
Patient-Reported Experiences with Dimethyltryptamine for Cluster Headache: An AI-Assisted Sentiment Analysis of Online Forums
Favorite
E 64
Patient-reported outcomes (PROs) for patients prescribed only acute or preventive rimegepant for migraine care via telemedicine at initial consultation and quarterly check-in
Favorite
F 2
Patterns of self-reported triggers within females and males with migraine and their association with prodromal and other migraine attack symptoms
Favorite
T 60
Patterns of Use and Impact of Over-the-Counter Rubs and Balms Among Persons with Migraine
Favorite
E 5
Perceived comfort with migraine treatments and control of migraine symptoms: results from the HEAD-US study
Favorite
F 5
Personality and Neuropsychological Measures in a Longitudinal Cohort of Cognitively Normal Individuals with Apolipoprotein E4 Alleles
Favorite
TR 5
Personalized changes in gut microbiome composition and predicted function comparing during migraine and post-migraine periods.
Favorite
T 35
Pharmacokinetic comparison of STS101 (Nasal DHE nasal powder) with liquid nasal spray, and injectable DHE formulations
Favorite
T 27
Pharmacokinetics and Safety of ASY202 for the Treatment of Acute Migraine Disease
Favorite
T 74
Physical Therapist-Delivered Biofeedback-Assisted Relaxation for Migraine: A Qualitative Analysis of Results from a Pilot Randomized Controlled Trial
Favorite
HE 24
Pilot Study of a Novel Parent Intervention for Pediatric Migraine: Preliminary Outcomes After One Year of Data Collection
Favorite
CR 18
Pneumocephalus and Intracranial Hypotension After Epidural Anesthesia: A Postpartum Case Report
Favorite
TR 11
Predicting CGRP Monoclonal Antibody Response Using Baseline Clinical and Biomarker Features: A Systematic Review and Meta-analysis
Favorite
T 75
Predictors of response to biofeedback-assisted relaxation: an exploratory analysis
Favorite
E 40
Pregnancy Outcomes After Onabotulinumtoxin A Exposure in Chronic Migraine: A Matched Cohort Study
Favorite
E 48
Presenteeism-Oriented Prioritization of Patient-Reported Outcome Measures in Migraine: A Bayesian Projection Predictive Variable Selection Approach
Favorite
CP 1
Prevalence and Phenotypes of Headache After Ischemic Stroke: A Systematic Review and Meta-Analysis
Favorite
E 13
Prevalence of Headache In Acute Upper Respiratory Tract Infections: A Systematic Review And Meta-Analysis
Favorite
E 33
Prevalence of Periodic Sleep Disorders and Motion Sickness in Patients Diagnosed with Migraine in a Tertiary Paediatric Headache Centre
Favorite
E 24
Prevalence, Disability, and Health-Care Utilization for Headache Disorders in North India
Favorite
HE 4
Primary Care Providers and Gepant Prescription: Barriers and Opportunities for Expanding Access to Migraine Treatment
Favorite
E 41
Primary Spoken Language Is Associated With Variation in Access to Neurologic Care and Chronic Migraine Diagnosis
Favorite
T 87
Prospective open-label pilot study of rimegepant as a treatment for cluster headache
Favorite
Q
HE 23
Quality Evaluation of American Headache Society Emergency Department Migraine Treatment Guidelines in a South Florida Tertiary Care Center
Favorite
R
T 62
Real-world effectiveness and safety of CGRP monoclonal antibodies in elderly migraine patients: a Korean multicenter study
Favorite
T 15
Real-World Impact of Eptinezumab Treatment on Migraine-Related Cognitive Symptoms in Participants in Whom ≥1 Prior CGRP-Targeted Therapy had Failed: 12-Month Results of a Prospective Study
Favorite
T 83
Real-World Longitudinal Outcomes of Acute Rimegepant in a Tertiary Migraine Population
Favorite
E 55
Real-World Migraine Treatment Patterns in the Era of CGRP-Targeted Therapies: Low Preventive Uptake and Dynamic Regimen Shifts: A Retrospective Claims Analysis
Favorite
E 7
Real-world Racial and Ethnic Differences in Migraine Treatment Access: Results from the HeAD-US Study
Favorite
T 76
Real-World Use of the Remote Electrical Neuromodulation (REN) Wearable for Migraine Management in Hawaii Demonstrates Positive Patient Outcomes: A Pilot Study
Favorite
TR 6
Reduced Cardiovagal activity is Strongly Associated with Treatment Resistance in Patients with Migraine
Favorite
T 77
Regional Patterns of Online Interest in Erenumab: A Comparative Study of the United States and Europe
Favorite
E 27
Relationship Between Migraine Related Stigma and Quality of Life in a Black/African American Sample
Favorite
E 22
Retrospective Review of Suicide Screening Results in VA Neurology Telehealth Program
Favorite
CR 7
Rimegepant as an Acute Therapy for Cluster Headache: A Case Report
Favorite
CR 16
Rimegepant for Medication Overuse Headache in a 93-Year-Old: A Novel Role for Calcitonin Gene-Related Peptide (CGRP) Antagonism
Favorite
T 22
Rimegepant for the Preventive Treatment of Migraine: A Phase 3, Randomized, Double-blind, Placebo-controlled Study in Adults from China
Favorite
S
T 42
Safety and Effectiveness of a Novel Implantable Neurostimulator for the Prevention of Resistant Migraine at 24 Months.
Favorite
T 10
Safety and Tolerability of Anti-PACAP Monoclonal Antibody Lu AG09222 when Co-administered with a Gepant in Participants with Migraine
Favorite
T 23
Safety, tolerability, and pharmacokinetics of PRT-064040 nasal spray following single and multiple ascending doses in healthy adults: a phase 1 study
Favorite
CR 19
Secondary hemicrania continua caused by idiopathic orbital inflammation
Favorite
TR 10
Serum Inflammatory Markers in Chronic versus Episodic Migraine: A Systematic Review and Meta-analysis
Favorite
CR 22
Sex-related thunderclap headache after exposure to Vonoprazan: A case report and review of literature
Favorite
TR 14
Sex-stratified genome-wide analyses of migraine uncover genetic links to cardiovascular disease, female-specific traits, and approved medications
Favorite
T 57
Sleep Disorders in Primary Headache: A Systematic Review and Meta-Analysis of Prevalence, Bidirectional Relationships, and Sleep-Targeted Intervention Efficacy
Favorite
E 32
Spoken Language and Limited English Proficiency as a Barrier to Care for the Acute Treatment of Migraine: Results from a Cross-Institutional Electronic Health Record
Favorite
CR 15
Spontaneous Intracranial Hypotension Presenting as Status Migrainosus in an Adolescent With Discordant Brain MRI Findings
Favorite
O 2
Stroke Risk Associated With CGRP Pathway Inhibitors in Adults With Migraine: Systematic Review and Meta-analysis of Randomized Trials
Favorite
CP 2
SUNCT After Traumatic Brain Injury Initially Misdiagnosed as Trigeminal Neuralgia
Favorite
T 19
Symbravo® (MoSEIC(TM) meloxicam and rizatriptan) for the Acute Treatment of Migraine: Post-hoc Composite Efficacy and Return to Function Endpoint Analysis from MOMENTUM
Favorite
T 33
Symbravo® (MoSEIC(TM) meloxicam and rizatriptan) for the Acute Treatment of Migraine: Post-hoc Composite Efficacy and Safety Endpoint Analysis of INTERCEPT and MOMENTUM
Favorite
T 30
Symbravo® (MoSEIC(TM) Meloxicam and Rizatriptan) for the Treatment of Migraine: Sustained Pain Relief and Pain Freedom Among 2-Hour Responders in the Phase 3 MOMENTUM and MOVEMENT Trials
Favorite
T 92
Symptom response to multiple epidural patches in patients with orthostatic headaches and no radiographic signs of spontaneous intracranial hypotension
Favorite
CP 12
Symptomatic low force head trauma and hypermobility
Favorite
PC 8
Synergistic antimigraine effects of combined vascular and neural targeting with lisinopril and memantine: preclinical support for clinical translation
Favorite
T
HE 7
Team-Based Migraine Preventive Care for Patients Receiving CGRP-Targeting Therapy: A Neurologist–Pharmacist Collaboration
Favorite
E 18
The Association of Acute Medication Utilization and Clinician Specialty in the Treatment of Pediatric Chronic Migraine: a Cross-Institutional Electronic Health Record Analysis
Favorite
T 73
The Association of Psychiatric Comorbidities with Preventive Medication Use in Patients with Migraine: a Cross-Institutional Electronic Health Record Analysis
Favorite
HE 18
The Development of a Just in Time Teaching Module to rapidly and effectively educate health care providers on updated American Headache Society evidence for acute management of migraine in the emergency room
Favorite
E 62
The EAPE Program: a migraine-friendly workplace initiative
Favorite
F 1
The Epidemiology of New Daily Persistent Headache at a Tertiary Headache Center: A Retrospective Analysis
Favorite
T 86
The Evidence Gap for Non-OnabotulinumtoxinA in Migraine Prevention: A Systematic Review of Dosing, Efficacy, and Injection Techniques
Favorite
E 26
The first use in Kazakhstan of ID-Migraine™ for screening and refined diagnostics of migraine among patients of the National Hospital of the Medical Center of the Presidential Administration of the Republic of Kazakhstan
Favorite
HE 19
The Global Neurology Headache Education Collaborative: Evaluating the Impact of an ICHD-3-Based Undergraduate Curriculum Intervention on Confidence and Diagnostic Accuracy in Headache and Craniofacial Pain Disorders
Favorite
T 34
The human pharmacokinetics of elismetrep, a TRPM8 migraine-associated channel blocker (MACB), are well-suited for a migraine therapeutic
Favorite
T 61
The impact of limited insurance coverage on the long-term persistence of CGRP monoclonal antibody therapy: A Multicenter, Real-World Study in Korea
Favorite
E 42
The Impact of Migraine on Imaging and Clinical Outcomes of Cerebral Small Vessel Disease
Favorite
T 7
The Impact of Ubrogepant on the Use of Other Migraine Acute Treatments, Opioid Discontinuation, and Healthcare Utilization: Results from a Pre-Post Opioid Subcohort Analysis
Favorite
E 9
The Long-Term Impact of COVID-19 on Encounters for Post-Traumatic Headache: an Interrupted Time-Series Analysis
Favorite
O 1
The Long-Term Impact of COVID-19 on Utilization of the Lumbar Puncture in the Diagnosis and Management of Idiopathic Intracranial Hypertension: an Interrupted Time-Series Analysis
Favorite
CR 14
The Role of Sleep Routines in Migraine Management
Favorite
T 72
The safety of CGRP-targeted therapies in cerebrovascular disease
Favorite
HE 1
The Unseen Burden: A Qualitative Exploration of Patient Experience in Chronic Headache Management
Favorite
T 9
Time course of rimegepant efficacy for the prevention of episodic migraine in a phase 4 trial enrolling participants with prior inadequate responses to 2 to 4 categories of non-migraine-specific oral preventive medications
Favorite
T 67
Title: Music Interventions for Migraine: A Scoping Review and Protocol
Favorite
CR 5
Toothpaste InduCed Trigeminal Autonomic Cephalalgia ("TICTAC" ): A case report
Favorite
T 18
Treatment outcomes with rimegepant versus other standard of care acute migraine medications in the observational CONFIDENCE study
Favorite
E 59
Treatment Patterns and Healthcare Utilization In Commercially Insured Adults With Incident Migraine (IFORM-II)
Favorite
T 12
Treatment Patterns, Medication Usage, Effectiveness, and Safety Among Veterans Treating with Remote Electrical Neuromodulation (REN)
Favorite
T 64
Trigeminal nerve blocks for medically intractable painful trigeminal neuropathy
Favorite
T 3
TRPM8 Channel Blockade with Elismetrep in a Phase 2B study: A Novel Approach for Treating Migraine
Favorite
T 59
Two-Step Sphenopalatine Ganglion Modulation Using Intranasal Lignocaine and High-Flow Oxygen for Acute Stroke-Associated Headache: A Prospective Case Series
Favorite
U
T 40
Ubrogepant Efficacy Based on Historical Cutaneous Allodynia and Triptan Response: Results from the PRODROME Trial
Favorite
O 3
Ultrasound-Guided Injection Improves Accuracy of Lateral Pterygoid Injections
Favorite
E 14
Unlocking The Power of Social Connection: Investigating the Role of Social Networks in the Experience and Management of Migraine
Favorite
HE 3
Utilizing Guided Clinical Decision Making in the Electronic Medical Record to Improve the Diagnosis and Treatment of Migraine in the Primary Care Setting
Favorite
V
E 17
Validation of the Brazilian Portuguese version of the Simulator Sickness Questionnaire and associated factors in patients with migraine
Favorite
E 12
Validity evidence for the MiCOAS 7-day recall measures: Results from an observational study
Favorite
T 53
Variability in Treatment Response Definitions Across Preventive Migraine
Favorite
E 29
Vascular Risk Prediction in Migraine: A Multimodality Risk Score Based on Artificial Intelligence-Electrocardiogram Output, Echocardiography, and Detailed Migraine Characteristics
Favorite
W
T 5
Weight Loss With Atogepant Versus Topiramate: Post hoc Analysis of the Head-to-Head TEMPLE Trial
Favorite
E 28
When Patient Experience and Diagnostic Criteria Diverge: Insights from the MiCOAS Study on Migraine Day Classification
Favorite
E 20
White Matter Hyperintensities in Migraine: Findings from a Mayo Clinic Cohort
Favorite
CP 8
Who Responds to Treatment? Predictive Insights from a Cervical-Based Model in Migraine
Favorite
